143 related articles for article (PubMed ID: 36343692)
1. The cardioprotective potentials and the involved mechanisms of phenolic acids in drug-induced cardiotoxicity.
Liu X; Tian R; Tao H; Wu J; Yang L; Zhang Y; Meng X
Eur J Pharmacol; 2022 Dec; 936():175362. PubMed ID: 36343692
[TBL] [Abstract][Full Text] [Related]
2. The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.
Razavi-Azarkhiavi K; Iranshahy M; Sahebkar A; Shirani K; Karimi G
Nutr Cancer; 2016; 68(6):892-917. PubMed ID: 27341037
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity.
Ojha S; Al Taee H; Goyal S; Mahajan UB; Patil CR; Arya DS; Rajesh M
Oxid Med Cell Longev; 2016; 2016():5724973. PubMed ID: 27313831
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity.
Liu H; Wang H; Xiang D; Guo W
Mini Rev Med Chem; 2017; 17(1):44-50. PubMed ID: 27337969
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity linked to anticancer agents and cardioprotective strategy.
Khairnar SI; Kulkarni YA; Singh K
Arch Pharm Res; 2022 Oct; 45(10):704-730. PubMed ID: 36306018
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of curcumin and piperine combination against cyclophosphamide-induced cardiotoxicity.
Chakraborty M; Bhattacharjee A; Kamath JV
Indian J Pharmacol; 2017; 49(1):65-70. PubMed ID: 28458425
[TBL] [Abstract][Full Text] [Related]
7. Natural Bioactive as a Potential Therapeutic Approach for the Management of Cyclophosphamide-induced Cardiotoxicity.
Iqubal A; Wasim M; Ashraf M; Najmi AK; Syed MA; Ali J; Haque SE
Curr Top Med Chem; 2021; 21(29):2647-2670. PubMed ID: 34392821
[TBL] [Abstract][Full Text] [Related]
8. The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review.
Syahputra RA; Harahap U; Dalimunthe A; Nasution MP; Satria D
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209107
[TBL] [Abstract][Full Text] [Related]
9. Progress on the cardiotoxicity of sunitinib: Prognostic significance, mechanism and protective therapies.
Yang Y; Bu P
Chem Biol Interact; 2016 Sep; 257():125-31. PubMed ID: 27531228
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway.
Yang L; Luo C; Chen C; Wang X; Shi W; Liu J
Br J Pharmacol; 2016 Jan; 173(2):357-71. PubMed ID: 26507774
[TBL] [Abstract][Full Text] [Related]
11. The Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice.
Ezzat SM; El Gaafary M; El Sayed AM; Sabry OM; Ali ZY; Hafner S; Schmiech M; Jin L; Syrovets T; Simmet T
J Pharmacol Exp Ther; 2016 Aug; 358(2):262-70. PubMed ID: 27247000
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin.
Bishop S; Liu SJ
Phytomedicine; 2017 Dec; 36():210-216. PubMed ID: 29157817
[TBL] [Abstract][Full Text] [Related]
13. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
14. Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents.
Piska K; Koczurkiewicz P; Bucki A; Wójcik-Pszczoła K; Kołaczkowski M; Pękala E
Invest New Drugs; 2017 Jun; 35(3):375-385. PubMed ID: 28283780
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity, nitric oxide level modulation and cardio-protective potential of Kalanchoe Integra Var. Crenata (Andr.) Cuf Leaves in murine models.
Asiedu-Gyekye IJ; Arhin E; Arthur SA; N'guessan BB; Amponsah SK
J Ethnopharmacol; 2022 Jan; 283():114640. PubMed ID: 34606947
[TBL] [Abstract][Full Text] [Related]
16. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective and nephroprotective effects of Quercetin against different toxic agents.
Alasmari AF
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7425-7439. PubMed ID: 34919245
[TBL] [Abstract][Full Text] [Related]
18. The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity.
Ayza MA; Zewdie KA; Tesfaye BA; Wondafrash DZ; Berhe AH
Oxid Med Cell Longev; 2020; 2020():4965171. PubMed ID: 32454939
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity.
Skála M; Hanousková B; Skálová L; Matoušková P
Arch Toxicol; 2019 Jan; 93(1):1-9. PubMed ID: 30460422
[TBL] [Abstract][Full Text] [Related]
20. The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition.
Yousefian M; Hosseinzadeh H; Hayes AW; Hadizadeh F; Karimi G
J Pharm Pharmacol; 2022 Mar; 74(3):351-359. PubMed ID: 34562089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
